RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.010
-0.020 (-1.94%)
Apr 15, 2026, 3:13 PM EDT - Market open
RenovoRx Employees
RenovoRx had 17 employees as of December 31, 2025. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
$66,059
Profits / Employee
-$656,941
Market Cap
45.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 7 | 70.00% |
| Dec 31, 2024 | 10 | 2 | 25.00% |
| Mar 31, 2024 | 10 | 0 | - |
| Dec 31, 2023 | 8 | -1 | -11.11% |
| Sep 30, 2023 | 10 | 0 | - |
| Jun 30, 2023 | 10 | 0 | - |
| Mar 31, 2023 | 10 | 0 | - |
| Dec 31, 2022 | 9 | 3 | 50.00% |
| Sep 30, 2022 | 10 | 0 | - |
| Jun 30, 2022 | 10 | 2 | 25.00% |
| Mar 31, 2022 | 10 | 4 | 66.67% |
| Dec 31, 2021 | 6 | -3 | -33.33% |
| Sep 30, 2021 | 10 | 1 | 11.11% |
| Jun 30, 2021 | 8 | - | - |
| Mar 31, 2021 | 6 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NextCure | 40 |
| Lisata Therapeutics | 21 |
| Atossa Therapeutics | 16 |
| Rallybio | 14 |
| Hyperion DeFi | 14 |
| Nutriband | 13 |
| Rein Therapeutics | 10 |
| Annovis Bio | 7 |
RNXT News
- 1 day ago - Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx's TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting - GlobeNewsWire
- 7 days ago - RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum - GlobeNewsWire
- 14 days ago - RenovoRx Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 - GlobeNewsWire
- 15 days ago - RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 20 days ago - RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment - GlobeNewsWire
- 23 days ago - RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement - GlobeNewsWire
- 26 days ago - RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET - GlobeNewsWire
- 4 weeks ago - RenovoRx Announces $10 Million at Market Private Placement - GlobeNewsWire